Delivery Order SPE2DB22D1002-SPE2DB24FKYK5
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,938.37 firm fixed-price contract is for the delivery of 4,567,472,969 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of March 6, 2025 and is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,167.93, is for the delivery of 4,563,362,847 units of the medication Ondansetron ODT 4 mg tablets. The contract is a Firm Fixed Price, has no set-aside designation, and has a completion date of January 22, 2024. AmerisourceBergen holds a $999,999,999 IDC...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.64 firm fixed-price contract is for the delivery of 4,566,932,681 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of January 15, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,691.38 firm fixed price contract is for the delivery of Ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of January 31, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,707.55 firm fixed price delivery order is for the supply of 4,566,197,426 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a $5,735.58 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,397,986 units of Ondansetron ODT 4 mg tablets, with a completion date of November 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $5,612.18 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,401,649 units of ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of January 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,678.96, is for the delivery of 4,567,873,264 units of the medication Ondansetron ODT 4 mg tablet. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,937.55, is for the supply of Ondansetron ODT 4 mg tablets in 30-count packages. The contract has an ultimate completion date of January 23, 2024 and is a firm-fixed-price, non-set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,957.59, is for the delivery of 4,567,908,925 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet 30s. The contract is a firm fixed-price delivery order, without any set-aside designation, with a completion date of April 15, 2025. AmerisourceBergen holds a significant...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB24FKYK5Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,930.66 firm fixed-price contract is for the purchase of 4,563,753,739 units of the drug Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of February 26, 2024 and was awarded on February 23, 2024. There was no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing pharmaceutical products and medical supplies to military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 2/23/24 |